Skip to main content
Erschienen in: Archives of Osteoporosis 1/2019

01.12.2019 | Original Article

Differing impact of clinical factors on the risk of fracture in younger and older women in the general population and an osteoporosis clinic population

verfasst von: Rosa Lauppe, Kristina E. Åkesson, Östen Ljunggren, Anna Spångéus, Gustaf Ortsäter, Maurille Feudjo-Tepie, Oskar Ström

Erschienen in: Archives of Osteoporosis | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Summary

This study assesses the impact of risk factors for fracture in women aged 80+ and 60–79. The results suggest that risk assessment which fits younger women may not be suited for the 80+ strata as many common risk factors are less predictive in the older compared to the younger cohort.

Purpose

This study assesses whether the impact of classical risk factors for fracture due to osteoporosis is different in women aged 80+ and women aged 60–79. Since most prior research on the contribution of risk factors is based on patients below 80 years of age, this study aims to fill this knowledge gap to increase the accuracy of risk assessment in the oldest old.

Methods

Retrospective, observational cohort study using Swedish national health register data and BMD data from osteoporosis clinics. Women aged at least 60 were identified from a random sample of the general population and from the BMD databases and allocated to two populations representing patients at different stages of risk assessment. The relative impact of risk factors on fracture risk was assessed using multivariate competing risk regression with fracture as outcome and death as competing event.

Results

A total of 163,329 women were included from the general population (52,499 aged 80+) and 22,378 from the BMD databases (4563 aged 80+). The clinical risk factors with relatively highest effect on fracture risk in the older patients were prior fracture and hip T-score below − 2.5 SD. Other included risk factors showed lower impact in the older compared to the younger strata.

Conclusions

This study confirms our understanding of the key risk factors for fracture: age, prior fracture, and a low T-score. Regarding remaining risk factors, risk assessment which fits younger women may not be suited for the 80+ strata as many common risk factors are less predictive in the older compared to the younger cohort.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761–1767CrossRef Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359(9319):1761–1767CrossRef
2.
Zurück zum Zitat Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res 29(3):581–589CrossRef Amin S, Achenbach SJ, Atkinson EJ, Khosla S, Melton LJ (2014) Trends in fracture incidence: a population-based study over 20 years. J Bone Miner Res 29(3):581–589CrossRef
3.
Zurück zum Zitat Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 6(1):59–155CrossRef Ström O, Borgström F, Kanis JA, Compston J, Cooper C, McCloskey EV, Jönsson B (2011) Osteoporosis: burden, health care provision and opportunities in the EU. Arch Osteoporos 6(1):59–155CrossRef
5.
Zurück zum Zitat Gullberg B, Johnell O, Kanis J (1997) World-wide projections for hip fracture. Osteoporos Int 7(5):407–413CrossRef Gullberg B, Johnell O, Kanis J (1997) World-wide projections for hip fracture. Osteoporos Int 7(5):407–413CrossRef
6.
Zurück zum Zitat Rosengren BE, Karlsson MK (2014) The annual number of hip fractures in Sweden will double from year 2002 to 2050: projections based on local and nationwide data. Acta Orthop 85(3):234–237CrossRef Rosengren BE, Karlsson MK (2014) The annual number of hip fractures in Sweden will double from year 2002 to 2050: projections based on local and nationwide data. Acta Orthop 85(3):234–237CrossRef
7.
Zurück zum Zitat Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I, Järvinen M (1996) Epidemiology of hip fractures. Bone 18(1):S57–S63CrossRef Kannus P, Parkkari J, Sievänen H, Heinonen A, Vuori I, Järvinen M (1996) Epidemiology of hip fractures. Bone 18(1):S57–S63CrossRef
8.
Zurück zum Zitat Boonen S, Marin F, Mellstrom D, Xie L, Desaiah D, Krege JH, Rosen CJ (2006) Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc 54(5):782–789CrossRef Boonen S, Marin F, Mellstrom D, Xie L, Desaiah D, Krege JH, Rosen CJ (2006) Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective. J Am Geriatr Soc 54(5):782–789CrossRef
9.
Zurück zum Zitat Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P (2004) Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 52(11):1832–1839CrossRef Boonen S, McClung MR, Eastell R, El-Hajj Fuleihan G, Barton IP, Delmas P (2004) Safety and efficacy of risedronate in reducing fracture risk in osteoporotic women aged 80 and older: implications for the use of antiresorptive agents in the old and oldest old. J Am Geriatr Soc 52(11):1832–1839CrossRef
10.
Zurück zum Zitat McCloskey EV, Beneton M, Charlesworth D, Kayan K, de Takats D, Dey A, Orgee J, Ashford R, Forster M, Cliffe J (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 22(1):135–141CrossRef McCloskey EV, Beneton M, Charlesworth D, Kayan K, de Takats D, Dey A, Orgee J, Ashford R, Forster M, Cliffe J (2007) Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. J Bone Miner Res 22(1):135–141CrossRef
11.
Zurück zum Zitat McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344(5):333–340CrossRef McClung MR, Geusens P, Miller PD, Zippel H, Bensen WG, Roux C, Adami S, Fogelman I, Diamond T, Eastell R (2001) Effect of risedronate on the risk of hip fracture in elderly women. N Engl J Med 344(5):333–340CrossRef
12.
Zurück zum Zitat McClung MR, Boonen S, Törring O, Roux C, Rizzoli R, Bone HG, Benhamou CL, Lems WF, Minisola S, Halse J (2012) Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis. J Bone Miner Res 27(1):211–218CrossRef McClung MR, Boonen S, Törring O, Roux C, Rizzoli R, Bone HG, Benhamou CL, Lems WF, Minisola S, Halse J (2012) Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis. J Bone Miner Res 27(1):211–218CrossRef
13.
Zurück zum Zitat Seeman E, Vellas B, Benhamou C, Aquino JP, Semler J, Kaufman JM, Hoszowski K, Varela AR, Fiore C, Brixen K (2006) Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21(7):1113–1120CrossRef Seeman E, Vellas B, Benhamou C, Aquino JP, Semler J, Kaufman JM, Hoszowski K, Varela AR, Fiore C, Brixen K (2006) Strontium ranelate reduces the risk of vertebral and nonvertebral fractures in women eighty years of age and older. J Bone Miner Res 21(7):1113–1120CrossRef
14.
Zurück zum Zitat Rizzoli R, Branco J, Brandi M-L, Boonen S, Bruyère O, Cacoub P, Cooper C, Diez-Perez A, Duder J, Fielding R (2014) Management of osteoporosis of the oldest old. Osteoporos Int 25(11):2507–2529CrossRef Rizzoli R, Branco J, Brandi M-L, Boonen S, Bruyère O, Cacoub P, Cooper C, Diez-Perez A, Duder J, Fielding R (2014) Management of osteoporosis of the oldest old. Osteoporos Int 25(11):2507–2529CrossRef
15.
Zurück zum Zitat Landfeldt E, Ström O, Robbins S, Borgström F (2012) Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA). Osteoporos Int 23(2):433–443CrossRef Landfeldt E, Ström O, Robbins S, Borgström F (2012) Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA). Osteoporos Int 23(2):433–443CrossRef
16.
Zurück zum Zitat Leib ES, Saag KG, Adachi JD, Geusens PP, Binkley N, McCloskey EV, Hans DB (2011) Official positions for FRAX® clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX® of the 10 year risk of fracture: from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom 14(3):212–219CrossRef Leib ES, Saag KG, Adachi JD, Geusens PP, Binkley N, McCloskey EV, Hans DB (2011) Official positions for FRAX® clinical regarding glucocorticoids: the impact of the use of glucocorticoids on the estimate by FRAX® of the 10 year risk of fracture: from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®. J Clin Densitom 14(3):212–219CrossRef
17.
Zurück zum Zitat Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRef Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi J-C, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130–1139CrossRef
18.
Zurück zum Zitat Fraser L, Leslie W, Targownik L, Papaioannou A, Adachi J, Group CR (2013) The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int 24(4):1161–1168CrossRef Fraser L, Leslie W, Targownik L, Papaioannou A, Adachi J, Group CR (2013) The effect of proton pump inhibitors on fracture risk: report from the Canadian Multicenter Osteoporosis Study. Osteoporos Int 24(4):1161–1168CrossRef
19.
Zurück zum Zitat Åkerlund M (2007) ApoDos-Apotekets dosexpedierade läkemedel [ApoDos _The National Corporation of Swedish Pharmacies’ multi-dose dispensed medicines]. Apoteket AB Åkerlund M (2007) ApoDos-Apotekets dosexpedierade läkemedel [ApoDos _The National Corporation of Swedish Pharmacies’ multi-dose dispensed medicines]. Apoteket AB
20.
Zurück zum Zitat Socialsyrelsen (2016) Läkemedel som kan öka risken för fallskada eller mag-tarmblödning hos äldre Socialsyrelsen (2016) Läkemedel som kan öka risken för fallskada eller mag-tarmblödning hos äldre
21.
Zurück zum Zitat Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952–1960CrossRef Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA (2009) Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 169(21):1952–1960CrossRef
23.
Zurück zum Zitat Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496–509CrossRef Fine JP, Gray RJ (1999) A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 94(446):496–509CrossRef
24.
Zurück zum Zitat Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41(3):861–870CrossRef Andersen PK, Geskus RB, de Witte T, Putter H (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41(3):861–870CrossRef
25.
Zurück zum Zitat Coviello V, Boggess M (2004) Cumulative incidence estimation in the presence of competing risks. Stata J 4:103–112CrossRef Coviello V, Boggess M (2004) Cumulative incidence estimation in the presence of competing risks. Stata J 4:103–112CrossRef
26.
Zurück zum Zitat Royston P (2006) Explained variation for survival models. Stata J 6(1):83–96CrossRef Royston P (2006) Explained variation for survival models. Stata J 6(1):83–96CrossRef
Metadaten
Titel
Differing impact of clinical factors on the risk of fracture in younger and older women in the general population and an osteoporosis clinic population
verfasst von
Rosa Lauppe
Kristina E. Åkesson
Östen Ljunggren
Anna Spångéus
Gustaf Ortsäter
Maurille Feudjo-Tepie
Oskar Ström
Publikationsdatum
01.12.2019
Verlag
Springer London
Erschienen in
Archives of Osteoporosis / Ausgabe 1/2019
Print ISSN: 1862-3522
Elektronische ISSN: 1862-3514
DOI
https://doi.org/10.1007/s11657-019-0592-3

Weitere Artikel der Ausgabe 1/2019

Archives of Osteoporosis 1/2019 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.